Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topiramate plus hypothermia in term newborns with hypoxic ischemic encephalopathy: pilot pharmacology study
2010-018627-25Phase 3Active
- Sponsor
- Meyer Children's Hospital IRCCS
- Start
- Feb 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of topiramate in hypoxic-ischemic encephalopathy (HIE), sponsored by Meyer Children's Hospital IRCCS. Primary endpoints: Mortality at 18 months and Neurodevelopmental score at 18 months. Started Feb 2010; status: active.
02
Drugs
topiramate
03
Conditions
hypoxic-ischemic encephalopathy (HIE)
Beyond the preview
Go deeper on 2010-018627-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-018627-25.